Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations
Status:
Terminated
Trial end date:
2011-05-12
Target enrollment:
Participant gender:
Summary
This study is to determine the number of European Leukemia Network (ELN)guideline defined
treatment failure events from time of study entry in CML-CP patients with low imatinib trough
concentrations treated with nilotinib.